2170 Results

People

  1. Busam
    Busam
  2. Marghoob
    Marghoob
  3. Halpern
    Halpern
  4. Houghton
    Houghton
  5. Coit
    Coit
  6. Wolchok
    Wolchok
  7. Old
    Old
  8. Chapman
    Chapman
  9. Postow
    Postow
  10. Dusza
    Dusza

Groups

  1. Department of Medicine (1009)
  2. Melanoma Disease Management Team (710)
  3. Solid Tumor Oncology Division (575)
  4. Survivorship Research (510)
  5. Division of Subspecialty Medicine (420)
  6. GSK Faculty (404)
  7. Dermatology (393)
  8. Dermatology Service (387)
  9. Melanoma and Immunotherapeutics Service (380)
  10. Population Sciences Research Program (361)
  1. "melanoma"
Formats
  1. Journal Article (1939)
  2. Review (86)
  3. Editorial (32)
  4. Research Letter (28)
  5. Book Section (27)
  6. Conference Paper (19)
  7. Meeting Abstract (12)
  8. Guidelines (11)
  9. Miscellaneous (9)
  10. Correspondence (7)
Groups
  1. Department of Medicine (1009)
  2. Melanoma Disease Management Team (710)
  3. Solid Tumor Oncology Division (575)
  4. Survivorship Research (510)
  5. Division of Subspecialty Medicine (420)
  6. GSK Faculty (404)

More Groups

People
  1. Klaus Busam (217)
  2. Ashfaq Marghoob (212)
  3. Jedd Wolchok (180)
  4. Allan Halpern (153)
  5. Alan Houghton (138)
  6. Paul Chapman (125)

More People

Years
  1. 2025 (48)
  2. 2024 (94)
  3. 2023 (92)
  4. 2022 (94)
  5. 2021 (63)
  6. 2020 (76)

More Years

Publications
  1. Journal of the American Academy of Dermatology (89)
  2. Annals of Surgical Oncology (65)
  3. Journal of Clinical Oncology (65)
  4. Clinical Cancer Research (56)
  5. Cancer Research (48)
  6. Cancer (45)

More Publications

Publishers
  1. Elsevier Inc. (206)
  2. Springer (184)
  3. Wiley Blackwell (173)
  4. Lippincott Williams & Wilkins (166)
  5. American Association for Cancer Research (141)
  6. Mosby Elsevier (95)

More Publishers

Results (2170)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • NF1-mutated melanomas reveal distinct clinical characteristics depending on tumour origin and respond favourably to immune checkpoint inhibitors
    Journal Article

    Thielmann, C. M.; Chorti, E.; Matull, J.; Murali, R.; Zaremba, A.; Lodde, G.; Jansen, P.; Richter, L.; Kretz, J.; Möller, I.; more...
    European Journal of Cancer (2021)

    Fulltext@MSK | Save
  • Association of melanoma-risk variants with primary melanoma tumor prognostic characteristics and melanoma-specific survival in the GEM study
    Journal Article

    Davari, D. R.; Orlow, I.; Kanetsky, P. A.; Luo, L.; Busam, K. J.; Sharma, A.; Kricker, A.; Cust, A. E.; Anton-Culver, H.; Gruber, S. B.; more...
    Current Oncology (2021)

    Fulltext@MSK | Save
  • Early use of high-dose glucocorticoid for the management of irAE is associated with poorer survival in patients with advanced melanoma treated with anti-PD-1 monotherapy
    Journal Article

    Bai, X.; Hu, J.; Betof Warner, A.; Quach, H. T.; Cann, C. G.; Zhang, M. Z.; Si, L.; Tang, B.; Cui, C.; Yang, X.; more...
    Clinical Cancer Research (2021)

    Fulltext@MSK | Save
  • WNT as a driver and dependency in cancer
    Review

    Parsons, M. J.; Tammela, T.; Dow, L. E.
    Cancer Discovery (2021)

    Fulltext@MSK | Save
  • Skin cancer classification via convolutional neural networks: Systematic review of studies involving human experts
    Review

    Haggenmüller, S.; Maron, R. C.; Hekler, A.; Utikal, J. S.; Barata, C.; Barnhill, R. L.; Beltraminelli, H.; Berking, C.; Betz-Stablein, B.; Blum, A.; more...
    European Journal of Cancer (2021)

    Fulltext@MSK | Save
  • Reduction in the number of early melanomas diagnosed during the COVID-19 pandemic: A single-centre cohort study
    Research Letter

    Koch, E.; Villanueva, F.; Marchetti, M. A.; Abarzúa-Araya, Á; Cárdenas, C.; Castro, J. C.; Dominguez, F.; Droppelmann, K.; Droppelmann, N.; Galindo, H.; more...
    Journal of the European Academy of Dermatology and Venereology (2021)

    Fulltext@MSK | Save
  • Melanoma and racial health disparities in black individuals - Facts, fallacies, and fixes
    Editorial

    Marchetti, M. A.; Adamson, A. S.; Halpern, A. C.
    JAMA Dermatology (2021)

    Fulltext@MSK | Save
  • Comparative performance of predictors of death from thin (≤ 1·0 mm) melanoma
    Research Letter

    Claeson, M.; Baade, P.; Marchetti, M.; Brown, S.; Soyer, H. P.; Smithers, B. M.; Green, A. C.; Whiteman, D. C.; Khosrotehrani, K.
    British Journal of Dermatology (2021)

    Fulltext@MSK | Save
  • PET/CT scan and biopsy-driven approach for safe anti-PD-1 therapy discontinuation in patients with advanced melanoma
    Journal Article

    Gibney, G. T.; Zaemes, J.; Shand, S.; Shah, N. J.; Swoboda, D.; Gardner, K.; Radfar, A.; Petronic-Rosic, V.; Reilly, M. J.; Al-Refaie, W. B.; more...
    Journal for ImmunoTherapy of Cancer (2021)

    Fulltext@MSK | Save
  • Immune checkpoint inhibitors in patients with pre-existing psoriasis: Safety and efficacy
    Journal Article

    Halle, B. R.; Betof Warner, A.; Zaman, F. Y.; Haydon, A.; Bhave, P.; Dewan, A. K.; Ye, F.; Irlmeier, R.; Mehta, P.; Kurtansky, N. R.; more...
    Journal for ImmunoTherapy of Cancer (2021)

    Fulltext@MSK | Save